Nearly 60% of Weight Lost on 'Skinny Shots' May Rebound, Doctors Warn

The popular "skinny shots," a class of drugs known as GLP-1 agonists, are facing scrutiny over potential weight rebound after patients stop treatment. International clinical research indicates that nearly 60% of weight lost may return within a year if users discontinue the medication without maintaining a healthy lifestyle. This finding raises concerns for individuals opting for these drugs as a primary weight-loss solution.

These medications have become a favored option for many seeking to shed pounds. However, the prospect of regaining lost weight looms large for users. The data suggests that the drugs themselves are not a permanent fix. Sustainable results appear to depend heavily on accompanying lifestyle changes.

Medical professionals are emphasizing the critical role of diet and exercise in preventing weight regain. Experts highlight that the long-term success of weight management hinges on adopting and adhering to healthier habits. This includes balanced nutrition and regular physical activity, even after the medication is no longer being used. The focus is shifting towards a holistic approach to weight loss, integrating medication with lasting behavioral changes.